Skip to main content
Premium Trial:

Request an Annual Quote

... as Wyeth Expands Existing License to Ingenuity s Pathway Software

NEW YORK, Oct. 25 (GenomeWeb News) - Wyeth Pharmaceuticals has expanded its license for Ingenuity's Pathways Analysis application, Ingenuity said today.


Wyeth will deploy the latest release of the software to its researchers in discovery and development organizations worldwide, Ingenuity said.


Ingenuity Pathways Analysis 3.0 allows scientists to integrate their discoveries into Ingenuity networks for analysis and to create customized pathways for targets, biomarkers, disease areas and processes.